Results

Found 534 hits.

Search Results for: Quiz 2024 EMC D-PDM-DY-23: Dell PowerProtect Data Manager Deploy 2023 Exam Updated Vce Download 🌋 Copy URL ➥ www.pdfvce.com 🡄 open and search for ⇛ D-PDM-DY-23 ⇚ to download for free 🥇Latest D-PDM-DY-23 Test Testking – Page 39

Proposed diagnostic algorithm for patients with suspected mastocytosis: A proposal of the European Competence Network on Mastocytosis (ECNM)

199 Valent, P.+, Escribano, L., Broesby-Olsen, S., Hartmann, K., Grattan, C., Brockow, K., Niedoszytko, M., Nedoszytko, B., Oude Elberink, J. N., Kristensen, T., Butterfield, J. H., Triggiani, M., Alvarez-Twose, I., Reiter, A., Sperr, W. R., Sotlar, K., Yavuz, S., Kluin-Nelemans, H. C., Hermine, O., Radia, D., Gotlib, J., Orfao, A., Siebenhaar, F., Schwartz, L. B., Castells, M., Maurer, M. Horny, H.-P., Akin, C., Metcalfe, D. D., and Arock, M.: Proposed diagnostic algorithm for patients with suspected mastocytosis: A proposal of the European Competence Network on Mastocytosis (ECNM). Allergy 2014: 69; 1267-1274. IF: 6.03
more »

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study

204 Saini, S. S., Bindslev-Jensen, C., Maurer, M. Grob, J.-J., Baskan, E. B., Bradley, M. S., Canvin, J., Rahmaoui, A., Georgiou, P., Alpan, O., Spector, S., and Rosén, K.+: Efficacy and safety of Omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1-antihistamines: A randomized, placebo-controlled study. J. Invest. Dermatol. 2015: 135; 67-75. IF: 6.91
more »

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyreoperoxidase

114 Maurer, M.+ Altrichter, S., Bieber, T., Biedermann, T., Bräutigam, M., Seyfried, S, Brehler, R., Grabbe, J., Hunzelmann, N., Jakob, T., Jung, A., Kleine-Tebbe, J., Mempel, M., Meurer, M., Reich, K., Ruëff, F., Sengupta, K., Sieder, C., Simon, J. C., Wedi, B., Zuberbier, T., Mahler, V., and Staubach, P.: Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyreoperoxidase. J. Allergy Clin. Immunol. 2011: 128; 202-209. IF: 11.00

o.114

more »